NCT00716521View on ClinicalTrials.gov

Effect Of Treatment With Oral Zolpidem On Polysomnography And Actigraphy Measures In Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

11

Participants

Timeline

Start Date

July 31, 2008

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Methodology Study
Interventions
DRUG

placebo

single oral dose placebo

DRUG

zolpidem

single oral dose, 5 mg zolpidem

DRUG

zolpidem

single oral dose, 10 mg zolpidem

Trial Locations (1)

06511

Pfizer Investigational Site, New Haven

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY